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Will pharmacists working in general practice help tackle the current workload crisis? 
It is widely acknowledged that there is a workload crisis in UK general practice. In addition to the 
impact of population growth and an increase in the number of older people with complex health 
needs, GPs have also taken on a considerable amount of work previously undertaken in secondary 
care. The result has been a 16% increase in overall GP workload, over a seven-year period up to 
2014, according to a recent large-scale English study.1 So far, there is little sign that the promised 
increase in resource heralded in the five-year forward review2 is making a difference on the front 
line. 
One approach to tackling the workload crisis is to draw upon the skills of other healthcare 
professionals, with pharmacists being one example; particularly those that are able to prescribe. In 
this context, the investment from NHS England in expanding the number of pharmacists working in 
general practices is welcome. In addition to the pilot wave investment of £31 million for the first 
recruitment wave of 490,3 there is a commitment to invest an additional £100 million to part-fund 
1500 pharmacists to work in English general practices over the next 3-4 years.4  
There is a reasonable body of evidence confirming the benefits that pharmacists can bring by 
working in general practices. For example, pharmacists working in primary care can help with 
chronic disease management, and there is evidence that they can be effective for a wide variety of 
conditions5,6,7. They can also help more broadly with medicines optimisation5 and can work with GPs 
to reduce hazardous prescribing.8 From my experience of working with a practice-based pharmacist 
there are many other ways in which they can ease the burden on GPs, including taking on difficult 
prescribing challenges (titrating up or withdrawing medicines), undertaking complex medication 
reviews, taking on medicines reconciliation for patients discharged from hospital, and negotiating 
with patients about medicines changes for increased effectiveness and cost-control.  
Also, as highlighted in this edition of the BJGP, pharmacists are enthusiastic about their new roles in 
general practice.9 In a qualitative study in the South West of England, pharmacists were interviewed 
before and after a training programme aimed at equipping them for working in general practice. 
While recognising their ongoing training needs, and the challenges and uncertainties around their 
new roles, the pharmacists were willing to take some of the load off GPs. 
So, what is not to like about this expansion of pharmacists in English general practice? The main 
problem, is the funding model. The NHS England contribution to the costs of recruitment and 
employment is tapered from 60% in year one to 20% in year three.4 This means that general 
practices that have taken on a pharmacist are now having to give serious consideration to the 
opportunity costs of continuing to employ them in the longer term. When faced with 80% of the 
annual salary of a pharmacist, GPs in a fully staffed general practice (or federation of practices) will 
be asking whether any benefits of the pharmacist on their workload are sufficient for them to be 
prepared to reduce their drawings. In practices with staff shortages they will be asking whether they 
might be better off investing in more GP sessions or a full-time nurse. The problem is that however 
good pharmacists are, it is unlikely that they will reduce GP workload in the way that an additional 
GP or nurse would. Also, as far as I am aware, there is little or no evidence available on the impact of 
practice-based pharmacists on GP workload to enable GPs to make a fully informed decision on this 
issue.  
Therefore, I worry that unless the funding formula is changed we may find that this admirable 
scheme to expand the pharmacy workforce in general practice may run into the sand. I suspect that 
many general practices will be prepared to make a financial contribution to employing pharmacists, 
particularly where they genuinely reduce GP workload. However, previous studies suggest that the 
majority of the impact of practice-based pharmacists will be on quality and safety,5 rather than on 
GP workload, and it is reasonable to ask whether GPs or the government should be paying for this? If 
NHS England is serious about putting more resources into general practice and easing the burden on 
GPs a more generous approach is needed to the ongoing funding of practice-based pharmacists.  
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